Sethuraman Natarajan

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
10
Insider Sells Sum
$752,687.58

Insider Activity of Sethuraman Natarajan

According to the SEC Form 4 filings, Sethuraman Natarajan, being in a position of

  1. Chief Scientific Officer at Entrada Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 23460 shares for $358,982,
    over all time since 2023-04-17, has bought 0 shares, and sold 45299 shares for $752,688.

The largest sale of all time was on 2023-07-11 and amounted to 14852 shares of Entrada Therapeutics, Inc. for $267,915.

Biography of Sethuraman Natarajan

No biography is available at this moment.

2024-09-09SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
2,642
0.0071%
$15.09$39,862-0.2%
2024-09-06SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
600
0.0017%
$15.24$9,141+1.35%
2024-07-15SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
638
0.0024%
$18.00$11,4840%
2024-07-12SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
600
0.0023%
$18.00$10,8000%
2024-05-20SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
9,675
0.0284%
$15.19$146,944+2.15%
2024-05-17SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
8,305
0.0253%
$15.14$125,751+4.34%
2024-05-16SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
1,000
0.003%
$15.00$15,000+4.69%
2023-07-11SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
14,852
0.0459%
$18.04$267,915-18.27%
2023-07-10SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
3,026
0.0094%
$18.00$54,474-18.13%
2023-04-17SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
3,961
0.0122%
$18.00$71,316-19.1%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.